Phase 3 Atrial Fibrillation Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have an irregular heart rhythm called atrial fibrillation (AF) that has been confirmed on a heart tracing (ECG), and who are already scheduled to have a procedure called electrical cardioversion (a controlled electric shock to reset the heart's rhythm) between 7 and 26 days from when they join the study
- People aged 55 years or older
- People who have signed a written consent form agreeing to take part
Who may not be able to join:
- People who are currently taking a type of medication called an SGLT2 inhibitor (a class of tablet often used for diabetes or heart conditions)
- People who have ever been diagnosed with heart failure, or currently have heart failure
- People who have Type 1 diabetes
- People whose kidneys are not working well enough, based on a blood test result that measures kidney function (called eGFR) being below a certain level (confirm with trial site)
- People who have had a procedure called pulmonary vein isolation (a treatment for irregular heart rhythm) within the past 3 months, or who have one planned during the 56-day study period
- People for whom SGLT2 inhibitor medications would be medically unsuitable or unsafe
- People whom the trial doctor considers should not take part, for any reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Karolina Szummer, MD PhD, Karolinska Institutet
Phone: +4681238000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Atrial fibrillation recurrence
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.